Live Breaking News & Updates on Candidiasis

Stay updated with breaking news from Candidiasis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Oteseconazole for Chronic Yeast Infections

The drug is the first to reach the market for recurrent vulvovaginal candidiasis, a condition that affects nearly 140 million women worldwide each year. ....

Drug Administration , Stephen Brand , Drug Development , Us Food And Drug Administration , Nited States Food And Drug Administration , Sexual Health , Ob Gyn And Womens Health Nursing , Adverse Effects , Side Effects , Patient Safety ,

Mundipharma and Cidara Therapeutics, Inc.: Rezafungin Awarded Promising Innovation Medicine (PIM) Designation by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Invasive Candidiasis

For Trade and Medical Media Only Rezafungin is a next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis ....

United States , San Diego , United Kingdom , Taylor Sandison , Patrick Bursey , Brian Sheehan , Jan Milton Edwards , Asia Pacific , Brian Ritchie , Community Register , Cidara Therapeutics Inc , European Commission , Drug Administration , Exchange Commission , Us Food Drug Administration , Lifesci Communications , European Medicines Agency , Securities Exchange , Healthcare Products Regulatory Agency , For Trade , Medical Media Only , Innovation Medicine , Early Access , Medicines Scheme , Cidara Therapeutics , Promising Innovative Medicine ,

A New Outbreak of C auris Has Been Reported in Brazil

A recent outbreak of the fungal infection Candida auris has Brazilian specialists warning clinicians to be on the lookout for infections, which they believe are underdiagnosed. ....

El Salvador , United Kingdom , Estado De Pernambuco , Queiroz Telles , Filipe Prohaska , Public Health Central Laboratories Lacens , Office For Infection Prevention , Ministry Of Health , University Of Paran , University Of Pernambuco , Services Of The Unified Health System Epi , Strategic Information On Health Surveillance , Department Of Health , Brazilian Society Of Infectious Diseases , Public Health Laboratories , Mycology Laboratory Unifesp , Mycology Laboratory Of The , Brazilian National Health Surveillance Agency Anvisa , Brazilian National Health Surveillance Agency , State Department , State Office , Infection Prevention , Strategic Information , Health Surveillance , Unified Health System , Public Health Central Laboratories ,

Candida Cleanses: Are Anti-Yeast Diets Just a Fad?

Despite uncertain health claims, diets set on eliminating Candida from our guts are seemingly everywhere. ....

Tufts University , United States , Rebel Wilson , Lisa Richards , Mahmoud Ghannoum , Amy Myers , Abby Langer , Carol Kumamoto , Centers For Disease , Medscape Medical , Debunking Misinformation , Medical Mycology , Case Western Reserve University , Total Gut Balance , Fix Your Mycobiome Fast , Complete Digestive , Disease Control , Candida Diet , These Diets Really , Fungal Infection , Skin And Soft Tissue Infection , Vaginal Candidiasis , Celiac Disease , Celiac Sprue , Gluten Sensitive Enteropathy , Prue Celiac ,

Cidara Therapeutics and Mundipharma Announce Positive Topline Results from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

For Trade and Medical Media Only Trial met FDA and EMA-pre-specified primary endpoints versus daily standard of care Data to support global regulatory filings in mid-2022 Cidara to host investor ....

United States , San Diego , Patrick Bursey , Brian Sheehan , Jan Milton Edwards , George Thompson , Asia Pacific , Jeffrey Stein , Brian Ritchie , University Of California , Community Register , School Of Medicine , Cidara Therapeutics Inc , European Commission , Drug Administration , Exchange Commission , Us Food Drug Administration , Lifesci Communications , European Medicines Agency , Securities Exchange , For Trade , Medical Media Only , New Drug Application , Marketing Authorization Application , Cause Mortality , Invasive Candidiasis ,